Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identification of Novel Genetic Variants and Biomarkers of Disease Progression in Arrhythmogenic Cardiomyopathy

NCT03049254 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT03049254
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03049254 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identification of Novel Genetic Variants and Biomarkers of Disease Progression in Arrhythmogenic Cardiomyopathy
Lead sponsor
Mayo Clinic
Phase
Observational
Overall status
Recruiting
Start date
February 9, 2018
Completion date
March 31, 2027
Enrollment
1,000 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

arrhythmogenic right ventricular cardiomyopathy, arrhythmogenic right ventricular dysplasia, arrhythmogenic ventricular cardiomyopathy, cardiac arrhythmia, cardiac sarcoidosis, cardiomyopathies, cardiovascular abnormalities, cardiovascular diseases, familial dilated cardiomyopathy, heart diseases, inflammatory cardiomyopathy, myocarditis, right ventricular outflow tract ventricular tachycardia, sarcoidosis, sudden cardiac arrest, sudden cardiac death, ventricular tachycardia